Sartorius Stedim Biotech Aktie
195,65
EUR
-1,05
EUR
-0,53
%
196,55
EUR
-4,15
EUR
-2,07
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
09.01.25 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
07.01.25 | Sartorius Stedim Biotech Outperform | RBC Capital Markets | |
22.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
17.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
03.10.24 | Sartorius Stedim Biotech Buy | Goldman Sachs Group Inc. | |
03.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
02.09.24 | Sartorius Stedim Biotech Outperform | RBC Capital Markets | |
29.07.24 | Sartorius Stedim Biotech Underperform | Bernstein Research | |
Werbung
|
|||
27.06.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
12.03.24 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
29.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
06.09.23 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
20.06.23 | Sartorius Stedim Biotech Buy | UBS AG | |
19.06.23 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
07.03.23 | Sartorius Stedim Biotech Buy | HSBC | |
22.07.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
04.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
22.04.22 | Sartorius Stedim Biotech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. |
Werbung